Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

2.

Development of a homogeneous competitive immunoassay for phosphorylated protein antigen based on the enhanced fluorescence resonance energy transfer technology.

Ohiro Y, Ueda H, Shibata N, Nagamune T.

J Biosci Bioeng. 2010 Jan;109(1):15-9. doi: 10.1016/j.jbiosc.2009.07.004. Epub 2009 Jul 29.

PMID:
20129075
3.
4.

Measuring ERK Activity Dynamics in Single Living Cells Using FRET Biosensors.

Blum Y, Fritz RD, Ryu H, Pertz O.

Methods Mol Biol. 2017;1487:203-221.

PMID:
27924569
5.
6.

Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Shapiro PS, Whalen AM, Tolwinski NS, Wilsbacher J, Froelich-Ammon SJ, Garcia M, Osheroff N, Ahn NG.

Mol Cell Biol. 1999 May;19(5):3551-60.

7.
8.

Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.

Hong SK, Yoon S, Moelling C, Arthan D, Park JI.

J Biol Chem. 2009 Nov 27;284(48):33006-18. doi: 10.1074/jbc.M109.012591. Epub 2009 Oct 5.

9.

Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation.

Yen A, Roberson MS, Varvayanis S.

In Vitro Cell Dev Biol Anim. 1999 Oct;35(9):527-32.

PMID:
10548434
10.

Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.

Vintman L, Nielsen S, Berner A, Reich R, Davidson B.

Cancer. 2005 Jun 1;103(11):2427-33.

11.

Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides.

Kelemen BR, Hsiao K, Goueli SA.

J Biol Chem. 2002 Mar 8;277(10):8741-8. Epub 2001 Dec 26.

13.

c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

Repici M, Mare L, Colombo A, Ploia C, Sclip A, Bonny C, Nicod P, Salmona M, Borsello T.

Neuroscience. 2009 Mar 3;159(1):94-103. doi: 10.1016/j.neuroscience.2008.11.049. Epub 2008 Dec 14.

PMID:
19135136
14.

Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice.

Liu Y, Duysen E, Yaktine AL, Au A, Wang W, Birt DF.

Carcinogenesis. 2001 Apr;22(4):607-12.

PMID:
11285196
15.

Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.

Shen CP, Tsimberg Y, Salvadore C, Meller E.

BMC Neurosci. 2004 Sep 20;5:36.

16.

Characterization of serotonin 5-hydroxytryptamine-1A receptor activation using a phospho-extracellular-signal regulated kinase 2 sensor.

Huwiler KG, Machleidt T, Chase L, Hanson B, Robers MB.

Anal Biochem. 2009 Oct 1;393(1):95-104. doi: 10.1016/j.ab.2009.06.018. Epub 2009 Jun 17.

PMID:
19539597
17.
19.

ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).

Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L.

Cancer Res. 2003 Apr 1;63(7):1684-95.

20.

Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3.

Matsuura I, Wang G, He D, Liu F.

Biochemistry. 2005 Sep 20;44(37):12546-53.

PMID:
16156666

Supplemental Content

Support Center